Neumora Therapeutics Inc (NMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 63,822 | 60,074 | 114,004 | 56,864 | 42,062 |
| Operating Income | -63,822 | -60,074 | -114,004 | -56,864 | -42,062 |
| Other Income | 5,247 | 6,353 | 5,542 | 3,837 | 3,519 |
| Pre-tax Income | -58,575 | -53,721 | -108,462 | -53,027 | -38,543 |
| Income Tax | 125 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -58,700 | -53,721 | -108,730 | -53,027 | -38,543 |
| Net Income | $-58,700 | $-53,721 | $-108,730 | $-53,027 | $-38,543 |
| EPS Basic Total Ops | -0.37 | -0.34 | 0.01 | -1.14 | -1.28 |
| EPS Basic Continuous Ops | -0.37 | -0.34 | 0.00 | -1.14 | -1.28 |
| EPS Diluted Total Ops | -0.37 | -0.34 | 0.01 | -1.14 | -1.28 |
| EPS Diluted Continuous Ops | -0.37 | -0.34 | 0.00 | -1.14 | -1.28 |
| EPS Diluted Before Non-Recurring Items | -0.37 | -0.34 | -0.71 | -1.14 | N/A |
| EBITDA(a) | $-65,827 | $-61,063 | $-114,511 | $-57,727 | $-43,031 |